A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
Clinical trial NCT06153095 · WITHDRAWN
Trial details
- NCT number
- NCT06153095
- Sponsor
- Lyell Immunopharma, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2025-01-09
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.